These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6268661)

  • 1. Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation.
    Weinberg JB; Muscato JJ; Niedel JE
    J Clin Invest; 1981 Sep; 68(3):621-30. PubMed ID: 6268661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of formylpeptide chemoattractant binding on neutrophils and monocytes from patients with head and neck cancer.
    Walter RJ; Danielson JR
    J Natl Cancer Inst; 1987 Jan; 78(1):61-9. PubMed ID: 3467131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of binding and internalization of human recombinant monocyte chemotactic and activating factor (MCAF) by monocytic cells.
    Wang JM; Hishinuma A; Oppenheim JJ; Matsushima K
    Cytokine; 1993 May; 5(3):264-75. PubMed ID: 8218939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of chemotactic peptide receptor modulation.
    Zigmond SH; Sullivan SJ; Lauffenburger DA
    J Cell Biol; 1982 Jan; 92(1):34-43. PubMed ID: 6276415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils.
    Niedel JE; Kahane I; Cuatrecasas P
    Science; 1979 Sep; 205(4413):1412-4. PubMed ID: 472759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-dependent chemiluminescence. Modulation of the N-formyl chemotactic peptide (FNLPNTL) mediated oxidative burst in human polymorphonuclear leukocytes (PMNL) by murine monoclonal antibody NMS-1.
    Schmitt M; Cochrane CG
    Free Radic Res Commun; 1987; 2(4-6):359-68. PubMed ID: 3504814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody NMS-1 increases N-formyl chemotactic peptide-mediated oxidative burst generation in human neutrophils.
    Schmitt M; Painter RG; von Tscharner V; Sklar LA; Jesaitis AJ; Fayle DH; Cochrane CG
    J Immunol; 1987 Dec; 139(12):4178-85. PubMed ID: 3693902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine.
    Falk W; Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):450-4. PubMed ID: 6282748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils.
    Waller A; Sutton KL; Kinzer-Ursem TL; Absood A; Traynor JR; Linderman JJ; Omann GM
    Biochemistry; 2004 Jun; 43(25):8204-16. PubMed ID: 15209517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton.
    Jesaitis AJ; Naemura JR; Sklar LA; Cochrane CG; Painter RG
    J Cell Biol; 1984 Apr; 98(4):1378-87. PubMed ID: 6325470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides.
    Øie CI; Snapkov I; Elvevold K; Sveinbjørnsson B; Smedsrød B
    PLoS One; 2016; 11(8):e0160602. PubMed ID: 27494406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of a bifunctional ligand of the formyl peptide receptor1 fused to the myc epitope.
    Charest-Morin X; Roy C; Fernandes MJ; Marceau F
    Int Immunopharmacol; 2015 Mar; 25(1):229-34. PubMed ID: 25681283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes.
    Yoshimura T; Leonard EJ
    J Immunol; 1990 Jul; 145(1):292-7. PubMed ID: 2162890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N alpha-formyl-norleucyl-leucyl-phenylalanyl chloromethylketone. A possible covalent agonist of the N alpha-formyl-methionyl-peptide receptor.
    Showell HJ; Mackin WM; Becker EL; Muthukumarasway N; Day AR; Freer R
    Mol Cell Biochem; 1981 Dec; 41():19-25. PubMed ID: 6276716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
    Van Epps DE; Simpson S; Bender JG; Chenoweth DE
    J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of formylpeptide receptor binding on rounded and polarized human neutrophils: cellular and receptor heterogeneity.
    Walter RJ; Marasco WA
    J Leukoc Biol; 1987 May; 41(5):377-91. PubMed ID: 3553401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist.
    Johansson B; Wymann MP; Holmgren-Peterson K; Magnusson KE
    J Cell Biol; 1993 Jun; 121(6):1281-9. PubMed ID: 8509449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detergent solubilization of the formyl peptide chemotactic receptor. Strategy based on covalent affinity labeling.
    Niedel J
    J Biol Chem; 1981 Sep; 256(17):9295-9. PubMed ID: 6267069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.